FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...
The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...
Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.
Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...
Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...
We are excited to work with Abbott to empower healthcare providers and people living with diabetes to see data from their ...
We are excited to work with Abbott to empower healthcare providers and people living with diabetes to see data from their FreeStyle Libre sensors on Tidepool and Tidepool+,” said Brandon Arbiter ...
Abbott's FreeStyle Libre 2 and 3 continuous glucose monitors no longer need to be removed for imaging tests. CGM readings during an MRI may be affected for up to an hour after the procedure. While ...